1. Home
  2. News
  3. NATCO Pharma Limited
  4. Press Release Jan 01 2022
More NATCO Pharma Limited news
NATCO Pharma LimitedNSE: NATCOPHARM

Press Release Jan 01 2022

Jan 1, 2022 at 6:38 PM EST · Issued by NATCO Pharma Limited

Filed with NSE · Jan 1, 2022 at 6:38 PM EST · 2 pages · English

On 6ix: 6ix.com/news/press-release-jan-01-2022-4

Watch NATCO Pharma's latest callNATCO Pharma (NSE:NATCOPHARM) Q2 2027 Earnings Call · Replay · Nov 13↗

NATCO Pharma Limited on 6ix

Earlier from NATCO Pharma

  • NATCO Pharma receives approval for Molnupiravir Capsules 200 mg for the treatment of Covid-19 in IndiaDec 29, 2021
  • Press Release Dec 28 2021Dec 28, 2021
  • Press Release Nov 18 2021Nov 18, 2021
  • Natco Pharma launches Everolimus tablets 10 mg in US marketOct 4, 2021
  • Press Release Oct 01 2021Oct 1, 2021

Later from NATCO Pharma

  • Press Release Jan 07 2022Jan 7, 2022
  • Press Release Jan 20 2022Jan 20, 2022
  • NATCO announces License Agreement with the Medicines Patent PoolJan 21, 2022
  • Press Release Mar 07 2022Mar 7, 2022
  • NATCO Announces Launch of the First Generic Version of Revlimid (Lenalidomide capsules), in the U.S. marketMar 8, 2022
All NATCO Pharma news releases↗

Follow NATCO Pharma into a list and get an email when it puts out news.

Follow NATCO Pharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer